Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.55 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | PTGES | O14684 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4862512 | 0.99 | ALDH1A1 (0.55) | ALDH1A1MAPTCASP3SENP7KDM4E | |
| SCHEMBL6034808 | 0.99 | ALDH1A1 (0.55) | ALDH1A1MAPTCASP3SENP7KDM4E | |
| Hydrochloric Acid SCHEMBL4860742 | 0.98 | ALDH1A1 (0.54) | ALDH1A1MAPTCASP3SENP7KDM4E | |
| SCHEMBL6035826 | 0.89 | ALDH1A1 (0.60) | ALDH1A1MAPTCASP3SENP7KDM4E | |
| Hydrochloric Acid SCHEMBL4850786 | 0.88 | ALDH1A1 (0.59) | ALDH1A1MAPTCASP3SENP7KDM4E | |
| SCHEMBL6034819 | 0.87 | ALDH1A1 (0.57) | ALDH1A1MAPTCASP3SENP7RXFP1 | |
| SCHEMBL6035340 | 0.86 | ALDH1A1 (0.51) | ALDH1A1MAPTCASP3SENP7KDM4E | |
| SCHEMBL6035081 | 0.86 | ALDH1A1 (0.51) | ALDH1A1MAPTCASP3SENP7KDM4E | |
| Hydrochloric Acid SCHEMBL4861101 | 0.86 | ALDH1A1 (0.50) | ALDH1A1MAPTCASP3SENP7KDM4E | |
| SCHEMBL6035048 | 0.86 | ALDH1A1 (0.56) | ALDH1A1MAPTCASP3SENP7RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7462628-B2 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-12-09 | — | — | US | disclosed |
| US-7462628-B2 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-12-09 | — | — | US | disclosed |
| US-20060063769-A1 | Preventives/remedies for urinary disturbance | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063769-A1 | Preventives/remedies for urinary disturbance | ACHE, BPHL, CHRM1 | ALDH1A1 118/4885MAPT 1965/4885CASP3 2953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.